Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study

Clinical article

Restricted access

Object

Vasospasm is the major cause of disability and death after aneurysmal subarachnoid hemorrhage (aSAH). Although the results of 2 randomized clinical trials demonstrated that statin decreases the incidence of symptomatic cerebral vasospasm after aSAH, retrospective studies have failed to confirm this. The authors conducted a prospective observational study to determine whether a standardized regimen of simvastatin would reduce the incidence of cerebral vasospasm and improve neurological outcomes in patients with aSAH.

Methods

Since 1991, all patients with aSAH admitted to the authors' institution have been prospectively followed up with standardized outcomes recording. Starting in September 2005, all patients admitted with aSAH were given enteral simvastatin (80 mg/day for 14 days) in addition to the standard care. The incidence of symptomatic cerebral vasospasm, length of hospitalization, in-hospital mortality rate, and discharge Glasgow Outcome Scale scores in these 170 patients were compared to data obtained in 170 consecutive patients who underwent treatment in our unit prior to the introduction of statin therapy.

Results

The 5-year study period included 340 consecutively treated patients (170 who received statins and 170 who did not). Patients who received simvastatin therapy were more frequently male (29 vs 20%) and had a smaller median aneurysm diameter (6 vs 7 mm). Baseline characteristics were otherwise similar between the cohorts. There were no differences in the incidence of symptomatic vasospasm (25.3 vs 30.5%; p = 0.277), in-hospital mortality rate (18 vs 15%; p = 0.468), length of hospitalization (21 ± 15 vs 19 ± 12 days; p = 0.281), or poor outcome at discharge (Glasgow Outcome Scale Scores 1–2: 21.7 vs 18.2%; p = 0.416) between the simvastatin and nonstatin cohorts. There were no statin-related complications.

Conclusions

The uniform introduction of simvastatin did not reduce the incidence of symptomatic cerebral vasospasm, death, or poor outcome in patients with aSAH. Simvastatin was well tolerated, but its benefit may be less than has been previously reported.

Abbreviations used in this paper: aSAH = aneurysmal subarachnoid hemorrhage; eNOS = endothelial nitric oxide synthase; GOS = Glasgow Outcome Scale; H & H = Hunt and Hess; HHH = hypertensive, hypervolemic, hemodilutional; IQR = interquartile range; SAH = subarachnoid hemorrhage; TCD = Transcranial Doppler.
Article Information

Contributor Notes

Address correspondence to: Rafael J. Tamargo, M.D., The Johns Hopkins University Hospital, Department of Neurosurgery, 600 North Wolfe Street, Meyer 8-181, Baltimore, Maryland 21287. email: rtamarg1@jhmi.edu.

© AANS, except where prohibited by US copyright law.

Headings
References
  • 1

    Aihara YKasuya HOnda HHori KTakeda J: Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke 32:2122172001

    • Search Google Scholar
    • Export Citation
  • 2

    Bellosta SVia DCanavesi MPfister PFumagalli RPaoletti R: HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler Thromb Vasc Biol 18:167116781998

    • Search Google Scholar
    • Export Citation
  • 3

    Buchanan JEPhillis JW: The role of nitric oxide in the regulation of cerebral blood flow. Brain Res 610:2482551993

  • 4

    Bulsara KRCoates JRAgrawal VKEifler DMWagner-Mann CCDurham HE: Effect of combined simvastatin and cyclosporine compared with simvastatin alone on cerebral vasospasm after subarachnoid hemorrhage in a canine model. Neurosurg Focus 21:3E112006

    • Search Google Scholar
    • Export Citation
  • 5

    Chyatte DRusch NSundt TM Jr: Prevention of chronic experimental cerebral vasospasm with ibuprofen and high-dose methylprednisolone. J Neurosurg 59:9259321983

    • Search Google Scholar
    • Export Citation
  • 6

    Claassen JBernardini GLKreiter KBates JDu YECopeland D: Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke 32:201220202001

    • Search Google Scholar
    • Export Citation
  • 7

    Clatterbuck REGailloud POgata LGebremariam ADeitsch GNMurphy KJ: Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates. J Neurosurg 99:3763822003

    • Search Google Scholar
    • Export Citation
  • 8

    Clatterbuck REOshiro EMHoffman PADietsch GNPardoll DMTamargo RJ: Inhibition of vasospasm with lymphocyte function-associated antigen-1 monoclonal antibody in a femoral artery model in rats. J Neurosurg 97:6766822002

    • Search Google Scholar
    • Export Citation
  • 9

    Conway JETamargo RJ: Cocaine use is an independent risk factor for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 32:233823432001

    • Search Google Scholar
    • Export Citation
  • 10

    Dimmeler SHaendeler JZeiher AM: Regulation of endothelial cell apoptosis in atherothrombosis. Curr Opin Lipidol 13:5315362002

  • 11

    Dumont ASDumont RJChow MMLin CLCalisaneller TLey KF: Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 53:1231252003

    • Search Google Scholar
    • Export Citation
  • 12

    Endres MLaufs UHuang ZNakamura THuang PMoskowitz MA: Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 95:888088851998

    • Search Google Scholar
    • Export Citation
  • 13

    Fisher CMKistler JPDavis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:191980

    • Search Google Scholar
    • Export Citation
  • 14

    Frazier JLPradilla GWang PPTamargo RJ: Inhibition of cerebral vasospasm by intracranial delivery of ibuprofen from a controlled-release polymer in a rabbit model of subarachnoid hemorrhage. J Neurosurg 101:93982004

    • Search Google Scholar
    • Export Citation
  • 15

    Gallia GLTamargo RJ: Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage. Neurol Res 28:7507582006

    • Search Google Scholar
    • Export Citation
  • 16

    Handa YKubota TKaneko MTsuchida AKobayashi HKawano H: Expression of intercellular adhesion molecule 1 (ICAM-1) on the cerebral artery following subarachnoid haemorrhage in rats. Acta Neurochir (Wien) 132:92971995

    • Search Google Scholar
    • Export Citation
  • 17

    Hijdra Avan Gijn JNagelkerke NJVermeulen Mvan Crevel H: Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke 19:125012561988

    • Search Google Scholar
    • Export Citation
  • 18

    Hunt WEHess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14201968

    • Search Google Scholar
    • Export Citation
  • 19

    Inoha SInamura TIkezaki KNakamizo AAmano TFukui M: Type V phosphodiesterase expression in cerebral arteries with vasospasm after subarachnoid hemorrhage in a canine model. Neurol Res 24:6076122002

    • Search Google Scholar
    • Export Citation
  • 20

    Jennett BBond M: Assessment of outcome after severe brain damage. Lancet 1:4804841975

  • 21

    Kayikcioglu MPayzin SYavuzgil OKultursay HCan LHSoydan I: Benefits of statin treatment in cardiac syndrome-X1. Eur Heart J 24:199920052003

    • Search Google Scholar
    • Export Citation
  • 22

    Kramer AHGurka MJNathan BDumont ASKassell NFBleck TP: Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage. Neurosurgery 62:4224302008

    • Search Google Scholar
    • Export Citation
  • 23

    Kreiter KTCopeland DBernardini GLBates JEPeery SClaassen J: Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke 33:2002082002

    • Search Google Scholar
    • Export Citation
  • 24

    Laufs UFata VLLiao JK: Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J Biol Chem 272:31725317291997

    • Search Google Scholar
    • Export Citation
  • 25

    Loch Macdonald R: Management of cerebral vasospasm. Neurosurg Rev 29:1791932006

  • 26

    Lynch JRWang HMcGirt MJFloyd JFriedman AHCoon AL: Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 36:202420262005

    • Search Google Scholar
    • Export Citation
  • 27

    Mayberg MRBatjer HHDacey RDiringer MHaley ECHeros RC: Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation 90:259226051994

    • Search Google Scholar
    • Export Citation
  • 28

    McGirt MJBlessing RAlexander MJNimjee SMWoodworth GFFriedman AH: Risk of cerebral vasospasm after subarachnoid hemorrhage reduced by statin therapy: a multivariate analysis of an institutional experience. J Neurosurg 105:6716742006

    • Search Google Scholar
    • Export Citation
  • 29

    McGirt MJBlessing RPGoldstein LB: Transcranial Doppler monitoring and clinical decision-making after subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 12:88922003

    • Search Google Scholar
    • Export Citation
  • 30

    McGirt MJLynch JRParra ASheng HPearlstein RDLaskowitz DT: Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 33:295029562002

    • Search Google Scholar
    • Export Citation
  • 31

    McGirt MJPradilla GLegnani FGThai QARecinos PFTamargo RJ: Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. Neurosurgery 58:9459512006

    • Search Google Scholar
    • Export Citation
  • 32

    Mocco JMack WJKim GHLozier APLaufer IKreiter KT: Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 97:5375412002

    • Search Google Scholar
    • Export Citation
  • 33

    Moskowitz SIAhrens CProvencio JJChow MRasmussen PA: Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhage. Surg Neurol [Epub ahead of print]2008

    • Search Google Scholar
    • Export Citation
  • 34

    Parra AKreiter KTWilliams SSciacca RMack WJNaidech AM: Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study. Neurosurgery 56:4764842005

    • Search Google Scholar
    • Export Citation
  • 35

    Pluta RM: Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther 105:23562005

  • 36

    Polin RSBavbek MShaffrey MEBillups KBogaev CAKassell NF: Detection of soluble E-selectin, ICAM-1, VCAM-1, and L-selectin in the cerebrospinal fluid of patients after subarachnoid hemorrhage. J Neurosurg 89:5595671998

    • Search Google Scholar
    • Export Citation
  • 37

    Pradilla GWang PPLegnani FGOgata LDietsch GNTamargo RJ: Prevention of vasospasm by anti-CD11/CD18 monoclonal antibody therapy following subarachnoid hemorrhage in rabbits. J Neurosurg 101:88922004

    • Search Google Scholar
    • Export Citation
  • 38

    Prado RWatson BDKuluz JDietrich WD: Endotheliumderived nitric oxide synthase inhibition. Effects on cerebral blood flow, pial artery diameter, and vascular morphology in rats. Stroke 23:111811241992

    • Search Google Scholar
    • Export Citation
  • 39

    Sills AK JrClatterbuck REThompson RCCohen PLTamargo RJ: Endothelial cell expression of intercellular adhesion molecule 1 in experimental posthemorrhagic vasospasm. Neurosurgery 41:4534611997

    • Search Google Scholar
    • Export Citation
  • 40

    Singhal ABTopcuoglu MADorer DJOgilvy CSCarter BSKoroshetz WJ: SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology 64:100810132005

    • Search Google Scholar
    • Export Citation
  • 41

    Suarez JITarr RWSelman WR: Aneurysmal subarachnoid hemorrhage. N Engl J Med 354:3873962006

  • 42

    Thai QAOshiro EMTamargo RJ: Inhibition of experimental vasospasm in rats with the periadventitial administration of ibuprofen using controlled-release polymers. Stroke 30:1401471999

    • Search Google Scholar
    • Export Citation
  • 43

    Tseng MYCzosnyka MRichards HPickard JDKirkpatrick PJ: Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 36:162716322005

    • Search Google Scholar
    • Export Citation
  • 44

    van Gijn JKerr RSRinkel GJ: Subarachnoid haemorrhage. Lancet 369:3063182007

  • 45

    Vaughan CJDelanty N: Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 30:196919731999

  • 46

    Williams JKSukhova GKHerrington DMLibby P: Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys. J Am Coll Cardiol 31:6846911998

    • Search Google Scholar
    • Export Citation
  • 47

    Wolf EWBanerjee ASoble-Smith JDohan FC JrWhite RPRobertson JT: Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor. J Neurosurg 89:2792881998

    • Search Google Scholar
    • Export Citation
  • 48

    Woszczyk ADeinsberger WBöker DK: Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm in patients with a subarachnoid haemorrhage. Acta Neurochir (Wien) 145:2572642003

    • Search Google Scholar
    • Export Citation
TrendMD
Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 288 285 74
Full Text Views 172 91 6
PDF Downloads 73 44 6
EPUB Downloads 0 0 0
PubMed
Google Scholar